Importantly, residual breast cancer cells surviving chemotherapy display stem-like traits (Creighton et al., 2009) and knocking down HIF-1α in these cells dampens their tumor-initiating capacity (Xiang et al., 2014). Here, HIF1A is linked to breast carcinoma.